Abstract
There is no “andropause” that corresponds to the female menopause, but normal aging in men is accompanied by a gradual decline in serum levels of testosterone and changes in the hypothalamic-pituitary-gonadal axis. Although there is a great deal of variability among individuals in this regard, and the process can be impacted by disease and medications, there has been a growing interest over the past decade in whether declining testosterone levels result in a significant number of older men becoming hypogonadal and whether replacement therapy might be beneficial. It is the purpose of this chapter to review the changes that occur with normal aging in the male reproductive axis and to discuss the issues that surround androgen replacement therapy in the older man.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bagatell CJ, Bremner WJ. Androgen and progestagen effects on plasma lipids. Prog in Cardiovas Dis 1995; 38: 255–271.
Baker HWG, Burger HG, deKretser DM, et al. Changes in the pituitary-testicular system with age. Clin Endocrinol (Oxf) 1976; 5:349–372.
Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983; 56:1278–1281.
Carani CM, Zini D, Baldini A, DellaCasa L, Ghizzani A, Marrama P. Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Arch Sex Behav 1990; 19:223–234.
Davidson JM, Camargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48:955–958.
Davidson JM, Chen JJ, Crapo L Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983: 57:71–77.
Drinka PJ, Jochen AL, Cuisinier M, Bloom R, Rudman I, Rudman D. Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc 1995; 43:899–901.
Ellyin FM, Gall EP, Cruz S. The long term beneficial effects of low dose testosterone in preventing osteoporosis in the aging male. In: Program and Abstracts of the 80th Annual Meeting of the Endocrine Society (USA) 1998; Abstract P2-644, p 383.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151:54–61.
Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970; 19:653–663.
Gaigulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79:997–1000.
Giusti G, Gonnelli P, Borrelli D, Fiorelli G, Forti G, Pazzagli M, Serio M. Age realted secretion of androstenedione, testosterone, and dihydrotestosterone by the human testis. Exp Gerontol 1975; 10:241–245.
Gray A, Berlin JA, McKinlay J, Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemol 1991a; 44:671–684.
Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991b; 73:1016–1025.
Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989; 110:526–531.
Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80:3546–3552.
Haddad G, Peachey H, Slipman C, Snyder PJ. Testosterone treatment improves body composition and muscle strength in hypogonadal men. In: Program and Abstracts of the 76th Annual Meeting of the Endocrine Society (USA), 1994; Abstract 1302, p 506.
Harman SM, Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980; 51:35–40.
Harman SM, Tsitouras PD, Costa PT, Blackman MR. Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1982; 54: 547–551.
Hemsell DL. Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 1974; 38:476–479.
Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982; 42:3232–3240.
Horton R, Hsieh P, Barberia J, Pages L, Cosgrove M. Altered blood androgens in elderly men with prostate hyperplasia. J Clin Endocrinol Metab 1975; 41:793–796.
Horton R. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male. J Am Geriatr Soc 1984; 32:380–385.
Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Sem Liver Dis 1987; 7:230–236.
Jackson JA, Kleerekoper M, Parfitt AM, et al. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987; 65:53–58.
Jockenhovel F, Vogel E, Reinhardt W, Reinwein D. Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res1997; 2:293–298.
Johnson L, Petty CS, Neaves WB. Influence of age on sperm production and testicular weights in men. J Reprod Fertil 1984a; 70:211–218.
Johnson L. Zane RS, Petty CS, Neaves WB. Quantification of the human Sertoli cell population: its distribution, relation to germ cell numbers, and age-related decline. Biol Reprod 1984b; 31:785–795.
Johnson L. Spermatogenesis and aging in the human. J Androl 1986; 7:331–354.
Kaler LW, Neaves WB. Attrition of the human Leydig cell production with advancing age. Anat Rec 1978; 192:513–518.
Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81:4358–4365.
Krauss DJ, Taub HA, Lantinga LL, Dunsky MH, Kelly CM. Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol 1991; 146:1566–1570.
Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combine laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab 1983; 57:557–562.
Lardinois CK. Mazzaferri EL. Cimetidine blocks testosterone synthesis. Arch Intern Med 1985; 145:920–022.
Longcope C. The effect of human chorionic gonadotropin on plasma steroid levels in young and old men. Steroids 1973; 21:583–592.
MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104:648–651.
Manni A, Pardridge WM, Cefalu MF, Nisula BC, Bardin CW, Santner SJ, Santen RJ. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab 1983; 61:705–710.
Marin P, Holmang S, Gustafsson E, et al. Androgen treatment of abdominally obese men. Obesity Res 1993; 1:245–251.
Marrama P, Montanini V. Celani MR, et al. Decrease in luteinizing hormone biological activity/immunoactivity ratio in elderly men. Maturitas 1984; 5:223–231.
Mazzi C, Riva LP, Bernasconi D. Gonadotrophins and plasma testosterone in senescence. In: James VHT, Serio M, Martini L, eds. The Endocrine Function of the Human Testis. Vol 2. New York: Academic Press; 1974: 51–66.
Morley JE, Kaiser FE, Perry HM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46:410–413.
Morley JE, Perry HM, Kaiser FE, et al. Effects of testosterone replacement therapy in older hypogonadal males: a preliminary study. J Am Geriatr Soc 1993; 41:149–152.
Moroz EV, Verkhratsky NS. Hypophyseal-gonadal systems during male aging. Arch Gerontol Geriatr 1985; 4:13–19.
Mulligan T, Retchin SM, Chinchilli VM, et al. The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc 1988; 36:520–524.
Muta K, Kato K-I, Akamine Y, Ibayashi H. Age-related changes in the feedback regulation of gonadotrophin secretion by sex steroids in men. Acta Endocrinol 1981; 96:154–162
Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986; 63:418–420.
Neaves WB, Johnson L. Porter JC, Parker CR, Petty CS. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984: 59:756–763.
Neaves WB, Johnson L, Petty CS. Age-related change in numbers of other interstitial cells in testes of adult men: evidence bearing on the fate of Leydig cells lost with increasing age. Biol Reprod 1985; 33:259–269.
Nieschlag E, Lammers U, Freischem CW, Langer K, Wickings EJ. Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 1982; 55:676–681.
O’Carroll R, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psych 1984; 145:146–151.
O’Carroll R, Shapiro C, Bancroft J. Androgens, behaviour and nocturnal erection in hypogonadal men: the effect of varying the replacement dose. Clin Endocrinol 1985; 23:527–538.
Oppenheim D, Klibanski A. Osteopenia in men with acquired hypogonadism: improvement with testosterone replacement. In: Program and Abstracts of the 71st Annual Meeting of the Endocrine Society (USA) 1989; Abstract 585, p169.
Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995; 16:87–116.
Paniagua R, Nistal M, Amat P, Rodriguez MC, Martin A. Seminiferous tubule involution in elderly men. Biol Reprod 1987; 36:939–947.
Panser LA, Rhodes T, Girman CJ, et al. Sexual function of men ages 40 to 79 years: the Olmsted county study of urinary symptoms and health status among men. J Am Geriatr Soc 1995; 43:1107–1111.
Pardridge WM, Landaw EM. Testosterone transport in brain: primary role of plasma protein-bound hormone. Am J. Physiol 1985; 249:E534–E542.
Pirke KM, Doerr P. Age related changes in free plasma testosterone, dihydrotestosterone, and oestradiol. Acta Endocrinol (Copenh) 1970; 80:171–178.
Pirke KM, Doerr P. Plasma dihydrotestosterone in normal adult males and its relation to testosterone. Acta Endocrinol (Copenh) 1975; 79:357–365.
Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl 1989; 10:366–371.
Pont A, Graybill JR, Craven PC, et al. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 1984; 144:2150–2153.
Reed R, Pearlmutter L, Yochum K, et al. The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc 1991; 39:555–561.
Riggs BL. Wahner HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Endocrinol Metab 1981; 67:328–335.
Rubens R, Dhont M, Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1974; 39:40–45.
Sakiyama R, Pardridge WM, Musto NA. Influx of testosterone-binding globulin (TeBG) and TeBG-bound sex steroid hormones into rat testis and prostate. J. Clin Endocrinol Metab 1988; 67:98–103.
Salmimies P, Kockett G, Pirke KW, Vogt HJ, Schill WB. Effects of testosterone replacement on sexual behavior in hypogonadal men. Arch Sex Behav 1982; 11:345–353.
Sandblom RE. Matsumoto AM, Schoene RB, et al. Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 1983; 308:508–510.
Santamaria JD, Prior JC, Fleetham JA. Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clin Endocrinol (Oxf) 1988; 28:461–470.
Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat. I. Effects of age, sex, and obesity. J Gerontol 1989; 44:M66–M73.
Sih R, Perry HM, Kaiser FE, Patrick P, Ross C, Morley JE. Testosterone therapy increases strength in older hypogonadal men. J Invest Med 1995: 43(Suppl 2): 300A.
Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82:1661–1667.
Skakkeback NE, Bancroft J, Davidson JM, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double-blind controlled study. Clin Endocrinol 1981; 14:49–61.
Snyder PJ, Reitano JF, Utiger RD. Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. J Clin Endocrinol Metab 1975; 41:938–945.
Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39:766–771.
Stearns EL, MacDonnell JA, Kaufman BJ, Padua R, Lucman TS, Winter JSD, Faiman C. Declining testicular function with age: hormonal and clinical correlates. Am J Med 1974: 74:761–766.
Takahashi J, Higashi Y, LaNasa JA, Yoshida K-I, Winters SJ, Oshima H, Troen P. Studies of the human testis. XVIII. Simultaneous measurement of nine intratesticular steroids: evidence for reduced mitochondrial function in testis of elderly men. J Clin Endocrinol Metab 1983; 56:1178–1187.
Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 1987; 65:1118–1126.
Tenover JS, Matsumoto AM, Clifton DK, Bremner WJ. Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy elderly men. J Gerontol Med Sci 1988; 43:M163–M169.
Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75:1092–1098.
Tenover JL. Effects of androgen supplementation in the aging male. In: Oddens BJ, Vermeulen A, eds. Androgens and the Aging Male. New York: Parthenon Publishing Group; 1996: 191–204.
Tenover JL. Testosterone and the aging male. J Androl 1997; 18:103–106.
Tenover JL. The male climacteric: fact or fiction? In: Morales A, ed. Current Topics in Erectile Dysfunction. London, Martin Dunitz Ltd, 1998 (in press).
Tomasic PV, Sollock RL, Armstrong DW, Shakir KMM. Osteoporosis in men with borderline idiopathic hypogonadotrophic hypogonadism. In: Program and Abstracts of the 76th Annual Meeting of the Endocrine Society (USA) 1994; Abstract 1043, p 461.
Urban RJ, Veldhuis JD, Blizzard RM, Dufau ML. Attenuated release of biologically active luteinizing hormone in healthy aging men. J Clin Endocrinol Metab 1988; 81:1020–1029.
Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995; 269:E820–E826.
Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992; 75:707–713.
Vermeulen A. Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab 1991; 73:221–224.
Vermeulen A, Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 1972; 34:730–735.
Vermeulen A, Verdonck L. Some studies on the biological significance of free testosterone. J Steroid Biochem 1972; 3:421–426.
Warner, BA, Dufau ML, Santen RJ. Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone. J Clin Endocrinol Metab 1985; 60:263–268.
Winters SJ, Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab 1982; 55:560–565.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers
About this chapter
Cite this chapter
Tenover, J.L. (1999). Male Senescence. In: Wang, C. (eds) Male Reproductive Function. Mineralogical Society Series, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-38145-9_7
Download citation
DOI: https://doi.org/10.1007/978-0-585-38145-9_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8520-2
Online ISBN: 978-0-585-38145-9
eBook Packages: Springer Book Archive